TrialHealth and quality of life outcomes2006

Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes.

Kristina Secnik Boye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.